[Translation] A single-center, randomized, open-label, two-dose, fasting/fed, single-dose, two-sequence, four-period, completely repeated crossover bioequivalence study of diclofenac sodium enteric-coated tablets in healthy Chinese subjects
以特一药业集团股份有限公司生产的双氯芬酸钠肠溶片(规格:25 mg)为受试制剂,以北京诺华制药有限公司持证的双氯芬酸钠肠溶片(商品名:扶他林®,规格:25 mg)为参比制剂,考察两制剂在空腹及餐后状态下单次给药的药代动力学参数及相对生物利用度,评价两制剂是否具有生物等效性。同时评价两种制剂在健康人体中的安全性和耐受性。
[Translation] Diclofenac sodium enteric-coated tablets (specification: 25 mg) produced by Teyi Pharmaceutical Group Co., Ltd. were used as the test preparation, and diclofenac sodium enteric-coated tablets (trade name: Voltaren®, specification: 25 mg) certified by Beijing Novatis Pharmaceutical Co., Ltd. were used as the reference preparation. The pharmacokinetic parameters and relative bioavailability of the two preparations after single administration in the fasting and postprandial states were investigated to evaluate whether the two preparations were bioequivalent. At the same time, the safety and tolerability of the two preparations in healthy humans were evaluated.